A clinical trial for therapeutic drug monitoring using microchip-based fluorescence polarization immunoassay

Tomoya Tachi, Tetsunari Hase, Yukihiro Okamoto, Noritada Kaji, Takeshi Arima, Hiroyuki Matsumoto, Masashi Kondo, Manabu Tokeshi, Yoshinori Hasegawa, Yoshinobu Baba

研究成果: Article査読

14 被引用数 (Scopus)

抄録

Microchip analysis is a promising method for therapeutic drug monitoring. This led us to evaluate a microchip-based fluorescence polarization immunoassay (FPIA) system for point-of-care testing on patients being treated with theophylline. The sera were collected from 20 patients being treated with theophylline. Fluorescence polarization was measured on the microchip and theophylline concentrations in serum were obtained. Regression analysis of the correlations was done between the results given by the microchip-based FPIA and the conventional cloned enzyme donor immunoassay (CEDIA), and between the results given by the microchip-based FPIA and the conventional particle-enhanced turbidimetric inhibition immunoassay (PETINIA). We successfully carried out a quantitative analysis of theophylline in serum at values near its therapeutic range in 65 s. The results obtained by the microchip-based FPIA correlated well with CEDIA and PETINIA results; the correlation coefficients (R 2) were 0.986 and 0.989, respectively. The FPIA system is a simple and rapid method for point-of-care testing of drugs in serum, and its accuracy is the same as the conventional CEDIA and PETINIA. It is essential to use real samples from patients and to confirm good correlations with conventional methods for a study on the realization of microchip.

本文言語English
ページ(範囲)2301-2305
ページ数5
ジャーナルAnalytical and Bioanalytical Chemistry
401
7
DOI
出版ステータスPublished - 10-2011
外部発表はい

All Science Journal Classification (ASJC) codes

  • Analytical Chemistry
  • Biochemistry

フィンガープリント 「A clinical trial for therapeutic drug monitoring using microchip-based fluorescence polarization immunoassay」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル